Cumulative live birth rates after GnRH-agonist triggering of final oocyte maturation in patients at risk of OHSS: A prospective, clinical cohort study

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 149, Issue 2, 2010, Pages 190-194

  Griesinger, Georg ^a   Berndt, Henriette ^a   Schultz, Laura ^a   Depenbusch, Marion ^a   Schultze Mosgau, Askan ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Frozen thawed embryo replacement cycle; GnRH agonist; GnRH antagonist; OHSS prevention; Ovarian hyperstimulation syndrome (OHSS); Ovarian stimulation; Vitrification

Indexed keywords

ESTRADIOL; ESTRADIOL VALERATE; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; MEDROXYPROGESTERONE ACETATE; PROGESTERONE; TRIPTORELIN; UNCLASSIFIED DRUG; UTROGEST;

ADULT; ALGORITHM; ARTICLE; BIRTH RATE; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CRYOPRESERVATION; EMBRYO TRANSFER; FEMALE; FREEZE THAWING; HUMAN; INCIDENCE; LIVE BIRTH; OOCYTE MATURATION; OUTCOME ASSESSMENT; OVARY HYPERSTIMULATION; PRIORITY JOURNAL; SAFETY; VITRIFICATION;

EID: 77549086507     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2009.12.030     Document Type: Article

References (28)

1. Felberbaum R.E., Reissmann T., Kupker W., et al. Preserved pituitary response under ovarian stimulation with HMG and GnRH antagonists (Cetrorelix) in women with tubal infertility. Eur J Obstet Gynecol Reprod Biol 61 (1995) 151-155
2. Fauser B.C., de Jong D., Olivennes F., et al. Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization. J Clin Endocrinol Metab 87 (2002) 709-715
3. Griesinger G., Diedrich K., Tarlatzis B.C., and Kolibianakis E.M. GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis. Reprod Biomed Online 13 (2006) 628-638
4. Engmann L., DiLuigi A., Schmidt D., Nulsen J., Maier D., and Benadiva C. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study. Fertil Steril 89 (2008) 84-91
5. Bodri D., Guillén J.J., Galindo A., Mataró D., Pujol A., and Coll O. Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study. Fertil Steril 91 (2009) 365-371
6. Humaidan P, Bredkjær HE, Westergaard LG, Yding Andersen C. 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study. Fertil Steril 2009 Feb 5 [Epub ahead of print].
7. Erb TM, Vitek W, Wakim AN. Gonadotropin-releasing hormone agonist or human chorionic gonadotropin for final oocyte maturation in an oocyte donor program. Fertil Steril. 2009 Jan 24 [Epub ahead of print].
8. Galindo A., Bodri D., Guillén J.J., Colodrón M., Vernaeve V., and Coll O. Triggering with HCG or GnRH agonist in GnRH antagonist treated oocyte donation cycles: a randomised clinical trial. Gynecol Endocrinol 25 (2009) 60-66
9. Acevedo B., Gomez-Palomares J.L., Ricciarelli E., and Hernández E.R. Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates. Fertil Steril 86 (2006) 1682-1687
10. Shapiro B.S., Daneshmand S.T., Garner F.C., Aguirre M., and Ross R. Comparison of human chorionic gonadotropin and gonadotropin-releasing hormone agonist for final oocyte maturation in oocyte donor cycles. Fertil Steril 88 (2007) 237-239
11. Griesinger G., Kolibianakis E.M., Papanikolaou E.G., Diedrich K., Van Steirteghem A., Devroey P., et al. Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles. Fertil Steril 88 (2007) 616-621
12. Erden H.F., Akman M.A., Çiray N., and Bahçeci M. The results of fresh and frozen thaw embryo transfer cycles of PCOS patients in which GnRH-antwere used together with GnRHa for LH surge. Fertil Steril 84 Suppl. 1 (2005) S164 (P-36)
13. Eldar-Geva T., Zylber-Haran E., Babayof R., Halevy-Shalem T., Ben-Chetrit A., Tsafrir A., et al. Similar outcome for cryopreserved embryo transfer following GnRH-antagonist/GnRH-agonist, GnRH-antagonist/HCG or long protocol ovarian stimulation. Reprod Biomed Online 14 (2007) 148-154
14. Humaidan P., Ejdrup Bredkjaer H., Bungum L., et al. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study. Hum Reprod 20 (2005) 1213-1220
15. Kolibianakis E., Schultze-Mosgau A., Schroer A., et al. A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of hCG, in patients undergoing IVF with GnRH antagonists. Hum Reprod 20 (2005) 2887-2892
16. Babayof R., Margalioth E.J., Huleihel M., Amash A., Zylber-Haran E., Gal M., et al. Serum inhibin A VEGF and TNF{alpha} levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial. Hum Reprod 21 (2006) 1260-1265
17. Youssef M., Griesinger G., Van Wely M., AL-inany H., and Van der Veen F. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist ART cycles. A systematic review and metaanalysis. Abstracts of the 25th Annual Meeting of ESHRE. Amsterdam, The Netherlands, 28 June-1 July, 2009. Hum Reprod 24 Suppl. 1 (2009) i115
18. Yding Andersen C., and Humaidan P. Characteristics of follicular fluid from women receiving either Buserelin or hCG to induce ovulation. Hum Reprod 20 Suppl. 1 (2005) 65
19. Nevo O., Eldar-Geva T., Kol S., and Itskovitz-Eldor J. Lower levels of inhibin A and pro-αC during the luteal phase after triggering oocyte maturation with a gonadotropin-releasing hormone agonist versus human chorionic gonadotropin. Fertil Steril 79 (2003) 1123-1128
20. Engmann L., Siano L., Schmidt D., Nulsen J., Maier D., and Benadiva C. GnRH agonist to induce oocyte maturation during IVF in patients at high risk of OHSS. Reprod Biomed Online 13 5 (2006) 639-644
21. Kol S., and Solt I. GnRH agonist for triggering final oocyte maturation in patients at risk of ovarian hyperstimulation syndrome: still a controversy?. J Assist Reprod Genet 25 (2008) 63-66
22. Griesinger G., von Otte S., Schroer A., et al. Elective cryopreservation of all pronuclear oocytes after GnRH agonist triggering of final oocyte maturation in patients at risk of developing OHSS: a prospective, observational proof-of-concept study. Hum Reprod 22 (2007) 1348-1352
23. Manzanares M.A., Gómez-Palomares J.L., Ricciarelli E., and Hernández E.R. Triggering ovulation with gonadotropin-releasing hormone agonist in in vitro fertilization patients with polycystic ovaries does not cause ovarian hyperstimulation syndrome despite very high estradiol levels. Fertil Steril (2009 Feb 5) [epub ahead of print]
24. Golan A., Ron-El R., and Herman A. Ovarian hyperstimulation syndrome: an update review. Obstet Gynecol Surv 44 (1989) 430-440
25. Navot D., Bergh P.A., and Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril 58 (1992) 249-261
26. Kuwayama M., Vajta G., Shoko I., and Kato O. Comparison of open and closed methods for vitrification of human embryos and the elimination of potential contamination. Reprod Biomed Online 11 (2005) 608-614
27. Bals-Pratsch M., Al-Hasani S., Schopper B., Diedrich C., Hoepfner A.S., Weiss J., et al. A simple, inexpensive and effective artificial cycle with exogenous transdermal oestradiol and vaginal progesterone for the transfer of cryopreserved pronucleated human oocytes in women with normal cycles. Hum Reprod 14(Suppl) (1999) 222-230
28. Kolibianakis E.M., Collins J., Tarlatzis B.C., Devroey P., Diedrich K., and Griesinger G. Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. Hum Reprod Update 12 (2006) 651-671